ATH 0.00% 0.3¢ alterity therapeutics limited

appendix 3b new shares, page-66

  1. 3,401 Posts.
    lightbulb Created with Sketch. 72
    I raised the idea of pbt2 uses being delineated for licensing and trial purposes a couple of weeks ago.if holding onto hd whilst partnering for ad is possible,this would stand the co in as good a state as any at a similar stage.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.